Product Features

[Product features]

1. Selected Strains with High Antigenicity
The vaccine utilizes meticulously cloned and screened Newcastle disease strain La Sota, avian influenza subtype H9 strain SS, and infectious bronchitis strain M41, providing effective cross-protection against prevalent avian influenza subtype H9, infectious bronchitis, and Newcastle disease nationwide.

2. High Viral Titer and Superior Antibody Response
Advanced antigen ultrafiltration and concentration technology ensures highly purified antigens, resulting in excellent antibody uniformity, high antibody levels, and prolonged immunity duration.

3. Advanced Process Ensures Product Stability
The application of advanced equipment and processes such as centrifugation and filtration ensures low residual endotoxin (≤50 EU/ml), total protein content (≤1 mg/ml), and formaldehyde content (≤ 0.02%, only one-tenth of the national standard). The vaccine features uniform particle size, low viscosity, and high stability.

4. High-Quality Adjuvant with Minimal Stress
Imported food-grade adjuvants and raw materials are used to minimize immunization stress, promote rapid absorption, and ensure safer injection.

[Ingredients] 

Each dosage (0.5ml as one dosage) contains inactivated NDV (Newcastle disease strain M41, strain La Sota) ≥10^8.3EID₅₀ , IBV (infectious bronchitis virus, strain M41) ≥10^6.3 EID₅₀ and AIV (subtype H9 avian influenza virus, strain SS) ≥10^7.3 EID₅₀.

[Indication]

It is used to prevent NDV, IBV and AIV infection in chickens,The immunity appears in 14-21 after vaccination,and the immunity period is 6 months.

[Properties]  Milky white emulsion

[Dosage & Administration] 

Subcutaneous back of the neck or imtramuscular injection.

0.3ml/bird of chickens within 4 weeks; 0.5ml/bird for chickens over 4 weeks. 

[Storage & Shelf life] 2~8℃, valid for 24 months

[Specification] 250ml/bottle  500m/bottle 

[Reg No.] SYSZ190912240